Teva Pharmaceutical Industries recently reported third-quarter 2025 earnings that exceeded analysts’ expectations, advanced ...

Teva Pharmaceutical (TEVA) is trading at new 5-year highs. ・Shares are up more than 40% over the past year. ・The stock has ...

Teva Pharmaceutical Industries Ltd ADR has reached a significant milestone, with its stock hitting a 52-week high at $32.02. This achievement marks a notable recovery and growth trajectory for the ...

Why Teva Pharmaceutical Industries Is Back on Investor Radars Teva Pharmaceutical Industries (NYSE:TEVA) has attracted fresh ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best affordable healthcare stocks to buy now. Teva ...

The big drugmaker unveiled its latest set of quarterly figures. Thanks to healthy rises in sales of key drugs, its revenue and profitability rose admirably. In its third quarter, Teva booked revenue ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Teva Pharmaceutical Industries (NYSE:TEVA) shares continued gains for seven straight sessions, as the stock closed 1% higher at $16.59 on Tuesday. The Israeli drugmaker gained about 5% in the ...

The big drugmaker unveiled its latest set of quarterly figures. In its third quarter, Teva booked revenue of $4.48 billion. That was 3% higher year over year, and much of that growth came from leading ...